Karyopharm Therapeutics Inc (KPTI) — Long-term Investment Intensity
Karyopharm Therapeutics Inc (KPTI) has a Long-term Investment Intensity of 0.8% as of September 2021. Long-term investments of $2.00 Million represent 0.8% of total assets of $254.09 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Karyopharm Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Karyopharm Therapeutics Inc Long-term Investment Intensity (2014–2020)
This chart shows how Karyopharm Therapeutics Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2014 to 2020. As of September 2021, the intensity stands at 0.8%, reflecting long-term investments of $2.00 Million against total assets of $254.09 Million USD. For the complete balance sheet picture, see KPTI current and non-current assets.
Annual Long-term Investment Intensity for Karyopharm Therapeutics Inc (2014–2020)
The table below presents the year-by-year Long-term Investment Intensity for Karyopharm Therapeutics Inc from 2014 to 2020, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Karyopharm Therapeutics Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 7.7% | $24.21 Million | $313.05 Million | ▲ +7.1 pp |
| 2019 | 0.7% | $2.02 Million | $294.96 Million | ▲ +0.1 pp |
| 2018 | 0.6% | $2.00 Million | $341.19 Million | ▼ -15.7 pp |
| 2017 | 16.3% | $29.40 Million | $180.29 Million | ▼ -8.9 pp |
| 2016 | 25.2% | $45.43 Million | $180.38 Million | ▲ +9.5 pp |
| 2015 | 15.7% | $33.88 Million | $215.44 Million | ▲ +11.8 pp |
| 2014 | 3.9% | $8.66 Million | $220.34 Million | — |